“In clinical management of depression, combining a reuptake inhibitor with presynaptic alpha2-autoreceptors significantly improves treatment outcomes, compared with monotherapy, a meta-analysis found. Clinicians should consider this approach as a viable first-line treatment for severe depression and for nonresponders, a team of German researchers concluded.”
Posted on March 2, 2022
Combination Antidepressant Treatment Outperforms Monotherapy in Meta-Analysis
Share
/plugin
Take the next step
If you’re living with a treatment-resistant mental health condition, you’re not out of options. Start with a consultation or reach out with your questions.
